NCT06286878View on ClinicalTrials.gov

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
Myocardial InfarctionAcute Coronary SyndromeDiabetesVentricular Dysfunction
Interventions
DRUG

Placebo

Patients will be randomized to use dapagliflozin or placebo in a double-blind way

DRUG

Dapagliflozin

Patients will be randomized to use dapagliflozin or placebo in a double-blind way

Trial Locations (1)

05403-900

RECRUITING

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER